跳到正文
← 返回论文列表与筛选
阅读说明

本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。

DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。

引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。

关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。

分类依据与纠错

AI 根据所提供的论文材料归类:摘要明确以双负对照处理隐藏混杂和选择偏误,并识别目标总体疫苗有效性,直接属于因果推断。

反馈分类问题

正在核对关联版本…

代码、数据与补充材料

正在核对对应版本的资源…

关注这篇论文的作者
Kendrick Qijun Li
Xu Shi
Wang Miao

疫苗有效性检测阴性设计研究中的双负对照推断

研究问题
检测阴性设计仍可能受未观测就医行为等混杂和样本选择偏误影响,如何识别并估计目标总体中的疫苗有效性?
方法与思路
作者同时利用负对照暴露与负对照结果变量,处理检测样本中的潜在隐藏偏误,并以模拟和医疗系统新冠疫苗数据展示方法。
材料陈述的贡献
摘要称,该方法为检测阴性设计提供面向目标总体的疫苗有效性识别与估计途径,针对残余混杂及选择引起的隐藏偏误展开。
阅读关注点
应核对两个负对照变量的有效性条件、样本选择机制及目标效应定义,并检查实际负对照选择是否支持识别所需限制。
阅读边界
仅据 OpenAlex 索引摘要,稿件版本未注明;负对照识别条件与疫苗效应数值未提供,不能据此认定所有未观测混杂或选择偏误均被消除。

原文摘要

The test-negative design (TND) has become a standard approach to evaluate vaccine effectiveness against the risk of acquiring infectious diseases in real-world settings, such as Influenza, Rotavirus, Dengue fever, and more recently COVID-19. In a TND study, individuals who experience symptoms and seek care are recruited and tested for the infectious disease which defines cases and controls. Despite TND's potential to reduce unobserved differences, in healthcare seeking behavior (HSB) between vaccinated and unvaccinated subjects, it remains subject to various potential biases. First, residual confounding may remain due to unobserved HSB occupation as healthcare worker, or previous infection history. Second, because selection into the TND sample is a common consequence of infection and HSB, collider stratification bias may exist when conditioning the analysis on tested samples, which further induces confounding by latent HSB. In this paper, we present a novel approach to identify and estimate vaccine effectiveness in the target population by carefully leveraging a pair of negative control exposure and outcome variables to account for potential hidden bias in TND studies. We illustrate our proposed method with extensive simulations and an application to study COVID-19 vaccine effectiveness using data from the University of Michigan Health System.

笔记与分组
相关领域论文